Research output per year
Research output per year
Personal profile
Headline
Instructor
Fingerprint
Dive into the research topics where Geming Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK
Filipowska, J., Cisneros, Z., Varghese, S. S., Leon-Rivera, N., Wang, P., Kang, R., Lu, G., Yuan, Y. C., Shih, H. P., Bhattacharya, S., Dhawan, S., Garcia-Ocaña, A., Kondegowda, N. G. & Vasavada, R. C., Feb 2025, In: Molecular Metabolism. 92, 102097.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers
Ables, J. L., Israel, L., Wood, O., Govindarajulu, U., Fremont, R. T., Banerjee, R., Liu, H., Cohen, J., Wang, P., Kumar, K., Lu, G., DeVita, R. J., Garcia-Ocaña, A., Murrough, J. W. & Stewart, A. F., Oct 2024, In: Journal of Psychopharmacology. 38, 10, p. 911-923 13 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Cholesterol 25-Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4
Zhang, L., Fang, Z., Zhu, Q., Yang, S., Fu, J., Sun, Z., Lu, G., Wei, C., Zhang, Z., Lee, K., Zhong, Y., Liu, R. & He, J. C., 7 Aug 2024, In: Advanced Science. 11, 29, 2309642.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitors
Karakose, E., Wang, X., Wang, P., Carcamo, S., Demircioglu, D., Lambertini, L., Wood, O., Kang, R., Lu, G., Scott, D. K., Garcia-Ocaña, A., Argmann, C., Sebra, R. P., Hasson, D. & Stewart, A. F., 17 Dec 2024, In: Cell Reports Medicine. 5, 12, 101832.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system
Rosselot, C., Li, Y., Wang, P., Alvarsson, A., Beliard, K., Lu, G., Kang, R., Li, R., Liu, H., Gillespie, V., Tzavaras, N., Kumar, K., DeVita, R. J., Stewart, A. F., Stanley, S. A. & Garcia-Ocaña, A., 10 Jul 2024, In: Science Translational Medicine. 16, 755, eadg3456.Research output: Contribution to journal › Article › peer-review
15 Scopus citations
Press/Media
-
Findings from City of Hope National Medical Center Provide New Insights into Molecular Metabolism (Lgr4 Is Essential for Maintaining 3-cell Homeostasis Through Suppression of Rank)
Lu, G., García-Ocaña, A. & Vasavada, R.
25/02/25
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai in the Area of Health and Medicine Described (Cycling Alpha Cells In Regenerative Drug-treated Human Pancreatic Islets May Serve As Key Beta Cell Progenitors)
Sebra, R., Lu, G., García-Ocaña, A., Karakose, E., Argmann, C., Lambertini, L. & Stewart, A.
3/02/25
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai Researcher Releases New Data on Clinical Trials and Studies (A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers)
Ables, J., Lu, G., Govindarajulu, U., García-Ocaña, A., Murrough, J. & Stewart, A.
4/10/24
1 item of Media coverage
Press/Media
-
Recent Findings in Xenografts Described by Researchers from City of Hope-Beckman Research Institute (Harmine and Exendin-4 Combination Therapy Safely Expands Human B Cell Mass In Vivo In a Mouse Xenograft System)
Lu, G., García-Ocaña, A., Li, R., Alvarsson, A. & Stanley, S.
28/08/24
1 item of Media coverage
Press/Media
-
Mount Sinai and City of Hope Scientists First to Demonstrate a Combination Treatment Can Increase Human Insulin-Producing Cells in Vivo
Alvarsson, A., Rosselot, C., Lu, G., Stanley, S., García-Ocaña, A. & Stewart, A.
10/07/24 → 11/07/24
5 items of Media coverage
Press/Media